Stock listing

Magle Chemoswed Holding Ab

Selected listing: A2P71A · LS · EUR · DE

Magle Chemoswed Holding Ab (Lang & Schwarz: A2P71A), Health Technology. Latest release Sep 22, 2026: MAGLE GROUP COMPLETES RESTRUCTURING OF ITS OUTSTANDING…

A2P71A:LSEURDEUpdated September 26, 2026

Ticker: Lang & Schwarz: A2P71A
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

About Magle Chemoswed Holding Ab

The company specializes in the development and production of pharmaceuticals and chemical products. As a publicly traded entity, it is subject to the regulations and reporting requirements of the Swedish market.

Latest news from Magle Chemoswed Holding Ab

MAGLE GROUP COMPLETES RESTRUCTURING OF ITS OUTSTANDING DEBT AND CAPITAL STRUCTURE

September 22, 2026

Magle Chemoswed Holding AB (publ) appoints Aaron Wong as Chief Executive Officer

September 10, 2026

Magle Chemoswed Holding AB (publ) initiates implementation of restructuring following successful written procedure

September 2, 2026

Magle Group announces additional drawdown under bridge loan facility

August 21, 2026

Magle Chemoswed Holding AB (publ) announces successful completion of the written procedure in relation to its senior secured bonds 2025/2028 and its senior secured bonds 2026/2028

July 30, 2026

All Magle Chemoswed Holding Ab news →

Research Magle Chemoswed Holding Ab

Magle Chemoswed Holding Ab company profile

View the public company page for Magle Chemoswed Holding Ab on 6ix.

Magle Chemoswed Holding Ab news

Read company news and market updates connected to Magle Chemoswed Holding Ab.

Magle Chemoswed Holding Ab investor events

Find investor webinars, events, and replay context for Magle Chemoswed Holding Ab.